Pages that link to "Q980926"
Jump to navigation
Jump to search
The following pages link to polymyositis (Q980926):
Displaying 50 items.
- tacrolimus (Q411648) (← links)
- rituximab (Q412323) (← links)
- methotrexate (Q422232) (← links)
- dermatomyositis (Q681160) (← links)
- Robert Erickson (Q2157033) (← links)
- mycophenolate mofetil (Q4567614) (← links)
- prednisolone (Q11426176) (← links)
- Factors predicting malignancy in patients with polymyositis and dermatomyostis: a systematic review and meta-analysis (Q21090635) (← links)
- Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis (Q24201580) (← links)
- Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis (Q24240771) (← links)
- Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis (Q24246333) (← links)
- Isolation and characterization of cDNA encoding the 80-kDa subunit protein of the human autoantigen Ku (p70/p80) recognized by autoantibodies from patients with scleroderma-polymyositis overlap syndrome (Q24558767) (← links)
- Cloning and characterization of the cDNA coding for a polymyositis-scleroderma overlap syndrome-related nucleolar 100-kD protein (Q24675094) (← links)
- Molecular characterization of an autoantigen of PM-Scl in the polymyositis/scleroderma overlap syndrome: a unique and complete human cDNA encoding an apparent 75-kD acidic protein of the nucleolar complex (Q24680898) (← links)
- First documented cure of a suggestive exogenous reinfection in polymyositis with same but multidrug resistant M. tuberculosis (Q24800980) (← links)
- The human exosome: an autoantigenic complex of exoribonucleases in myositis and scleroderma (Q24805333) (← links)
- Polymyositis and dermatomyositis: novel insights into the pathogenesis and potential therapeutic targets (Q26801749) (← links)
- Dermatomyositis and polymyositis: new treatment targets on the horizon (Q26823372) (← links)
- Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C- (Q27021322) (← links)
- Antiphospholipid syndrome and dermatomyositis/polymyositis: a rare association. (Q27693047) (← links)
- Wide cross-species aminoacyl-tRNA synthetase replacement in vivo: yeast cytoplasmic alanine enzyme replaced by human polymyositis serum antigen (Q27935944) (← links)
- Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study (Q28200349) (← links)
- Critical requirement for professional APCs in eliciting T cell responses to novel fragments of histidyl-tRNA synthetase (Jo-1) in Jo-1 antibody-positive polymyositis (Q28216870) (← links)
- Tropical spastic paraparesis and polymyositis--a still unfolding story (Q28240211) (← links)
- PM-Scl-75 is the main autoantigen in patients with the polymyositis/scleroderma overlap syndrome (Q28244087) (← links)
- Immune responses to DNA mismatch repair enzymes hMSH2 and hPMS1 in patients with pancreatic cancer, dermatomyositis and polymyositis (Q28247165) (← links)
- Marker antibodies in scleroderma and polymyositis: clinical associations (Q28253274) (← links)
- Evidence for MHC I-restricted CD8+ T-cell-mediated immunopathology in canine masticatory muscle myositis and polymyositis (Q28280390) (← links)
- Scleromyositis: a scleroderma/polymyositis overlap syndrome (Q28294012) (← links)
- C1D is a major autoantibody target in patients with the polymyositis-scleroderma overlap syndrome (Q28307830) (← links)
- Polymyositis due to D-penicillamine in a patient with systemic sclerosis (Q28315973) (← links)
- Polymyositis complicating D-penicillamine treatment (Q28325364) (← links)
- Penicillamine-induced polymyositis-dermatomyositis (Q28327492) (← links)
- Polymyositis syndrome, acute renal failure and disseminated intravascular coagulation probably caused by ampicillin hypersensitivity (author's transl) (Q28327722) (← links)
- Fenofibrate induced polymyositis (Q28328068) (← links)
- Drug induced polymyositis secondary to leuprolide acetate (Lupron) therapy for prostate carcinoma (Q28333978) (← links)
- D-penicillamine-induced polymyositis in rheumatoid arthritis (Q28334816) (← links)
- Cyclosporin A and intravenous immunoglobulin treatment in polymyositis/dermatomyositis (Q28344601) (← links)
- MRI guided muscle biopsy confirmed polymyositis diagnosis in a patient with interstitial lung disease (Q28360079) (← links)
- Polymyositis after propylthiouracil treatment for hyperthyroidism (Q28361454) (← links)
- Polymyositis with respiratory muscle weakness requiring mechanical ventilation in a patient with metastatic thymoma treated with octreotide (Q28373505) (← links)
- D-penicillamine-induced pemphigus, polymyositis and myasthenia (Q28377222) (← links)
- Polymyositis induced by tiopronine (Q28377493) (← links)
- A case of polymyositis in a patient with primary biliary cirrhosis treated with D-penicillamine (Q28378419) (← links)
- Respiratory muscle and pulmonary function in polymyositis and other proximal myopathies (Q28390530) (← links)
- The polymyositis-scleroderma autoantigen interacts with the helix-loop-helix proteins E12 and E47 (Q28566852) (← links)
- Current Perspectives on Imaging for Systemic Lupus Erythematosus, Systemic Sclerosis, and Dermatomyositis/Polymyositis (Q30244564) (← links)
- Polymyositis following Pandemic Influenza A (H1N1) and 2009-10 Seasonal Trivalent Vaccines (Q30420816) (← links)
- Pandemic unadjuvanted influenza A (H1N1) vaccine in dermatomyositis and polymyositis: immunogenicity independent of therapy and no harmful effect in disease. (Q30423188) (← links)
- Polymyositis and a thalamic mass. (Q30443096) (← links)